Dexcom Inc. (NSDQ:DXCM) said yesterday it launched full support for Apple‘s (NSDQ:AAPL) Apple Watch for its G5 mobile continuous glucose monitor The updated app will allow users to monitor their glucose data using the smartwatch, as well as viewing readings and trends and receiving notifications and alerts through the watch, which syncs to the app on […]
Dexcom
Dexcom Q3 beats on rev growth, misses EPS
Dexcom Inc. (NSDQ:DXCM) released its 3rd quarter earnings yesterday, reporting over 50% growth in revenue, but missing the Street’s expectations for earnings. Dexcom reported losses of $42.5 million, or 53¢ per share, on sales of $105.2 million for the 3 months ended September 30, 2015. That amounts to a 700%+ increase in losses from last […]
DexCom prelims top expectations, sends shares soaring
DexCom Inc. (NSDQ:DXCM) reported preliminary revenues for its 3rd quarter yesterday of approximately $105 million, sending shares up nearly 20%. That puts DexCom nearly $8 million ahead of street expectations, which guessed the company would bring in $97 million for the quarter. The number is also up $36 million, or 52% from the same quarter […]
Diabetes: Dexcom wins CE Mark for G5 CGM
Dexcom (NSDQ:DXCM) said today that it won CE Mark approval in the European Union for its G5 continuous glucose monitor, saying it expects to have the device available in several countries there in the coming weeks. San Diego-based Dexcom won pre-market approval from the FDA for the G5 device last month, touting it as the 1st approved CGM […]
Edwards Lifesciences, DexCom spike CGM development deal
Edwards Lifesciences (NYSE:EW) and DexCom (NSDQ:DXCM) last week agreed to spike their deal to develop continuous glucose monitoring technology for use in hospitals. The deal, inked in November 2008, originally included an exclusive license for Edwards for all of DexCom’s applicable technology for $13 million up front and another $24 million over 3 years in product development costs and […]
FDA clears Tandem Diabetes t:slim pump with DexCom’s G4 Platinum CGM
The FDA approved a version of the t:slim insulin pump made by Tandem Diabetes Care (NSDQ:TNDM) with an integrated G4 Platinum continuous glucose monitor made by Dexcom Inc. (NSDQ:DXCM), the companies said today. Shipments of the t:slim G4 insulin pump are expected to begin in October, they said. “The t:slim G4 pump combines our intuitive touch-screen interface and bright color display […]
Dexcom wins FDA nod for G5 CGM
Dexcom Inc. (NSDQ:DXCM) said today it won FDA pre-market approval for its G5 mobile continuous glucose monitor, the 1st approved monitor to send data directly to smartphones without a separate receiver. The new glucose monitor, approved for ages 2 and up, will use a smartphone as the primary display and can send the data to […]
DexCom inks partnership with Google Life Sciences
Dexcom Inc. (NSDQ:DXCM) said today it signed a partnership deal with the life sciences team at Google (NSDQ:GOOG) to jointly develop continuous glucose monitoring products. The new partnership will bring together Google’s miniaturized electronics platform and DexCom’s sensor technology, and looks to develop next-generation CGM devices that will be less expensive than existing technologies, San Diego, […]
Dexcom jumps on Q2 sales beat despite earnings miss
Dexcom Inc. (NSDQ:DXCM) shares jumped this week after the continuous glucose monitor maker posted sales growth of nearly 60%, handily beating the forecast on Wall Street and paring its losses by some 38%. San Diego-based Dexcom reported losses of -$3.7 million, or -5¢ per share, on sales of $93.2 million for the 3 months ended […]
Bigfoot acquires Asante assets, inks deal with Dexcom
Bigfoot Biomedical is making strides towards its goal of a bionic pancreas after inking a deal with Dexcom Inc. (NSDQ:DXCM), maker of continuous glucose monitors, and acquiring the assets of shuttered insulin pump maker Asante. Bigfoot also said it will be relocating to Milpitas, Calif., where Asante was headquartered. The deal signed with Dexcom is slated to […]
Diabetes: Glooko adds Dexcom, Insulet to platform
Glooko said yesterday that it inked deals with Dexcom (NSDQ:DXCM) and Insulet (NSDQ:PODD) to supply device data from both companies to its diabetes management platform. Glooko’s platform will now integrate Dexcom’s continuous glucose monitoring systems and Insulet’s OmniPod insulin management systems in a new version of the platform that’s slated for a summer release, the Palo Alto, Calif.-based company […]